Clinical Trial: Sequential vs. Combined Letrozole and Methotrexate for Tubal Ectopic Pregnancy.

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842796) titled 'Sequential vs. Combined Letrozole and Methotrexate for Tubal Ectopic Pregnancy.' on Sept. 21.

Brief Summary: This study evaluates two medical strategies designed to minimize surgical intervention and reduce methotrexate (MTX) exposure in women with undisturbed tubal ectopic pregnancy (TEP). Participants with undisturbed TEP and pre-treatment serum $\beta$-hCG levels $10% on Day 4, Letrozole is continued.

DRUG: Methotrexate

A single intramuscular injection of Methotrexate (50mg/m) is administered as rescue therapy, If beta-hCG drop is <10 on Day 4,

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Benha University

Information ...